Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Cardiovascular Diseases (Phase 1)
Cholangitis (Phase 3)
Cholangitis, Sclerosing (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Drug Interactions (Phase 1)
Dyslipidemias (Phase 2)
Geriatrics (Phase 1)
Glucose Intolerance (Phase 2)
Healthy Volunteers (Phase 1)
Insulin Resistance (Phase 2)
Kidney Diseases (Phase 1)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Metabolic Diseases (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 3)
Obesity (Phase 1)
Obesity, Abdominal (Phase 2)
Pharmacokinetics (Phase 1)
Renal Insufficiency (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue